统计整合来自细胞系的多组和药物查数据
Said El Bouhaddani1, Matthias Höllerhage2, Hae-Won Uh1
1Dept. Data science & Biostatistics, UMC Utrecht, Utrecht, Netherlands.
PLoS computational biology
|January 31, 2024
概括
我们使用POPLS-DA (概率数据集成) 开发了一种新的计算工作流程,用于分析多omics数据的同核蛋白病变. 这种方法将HSPA5和AT1抑制剂确定为潜在的治疗点,为帕金森病研究提供了新的方向.
科学领域:
- 计算生物学是一种计算生物学.
- 基因组学就是基因组学.
- 神经科学是一个神经科学.
背景情况:
- 包括帕金森病在内的同核蛋白病变是复杂的神经系统疾病.
- 目前的多学科数据集成方法难以有效地分析来自细胞系模型的各种数据集.
- 鉴定同核蛋白病变的可用药物标仍然是一个重大挑战.
研究的目的:
- 提出一种新的计算工作流程,用于联合分析来自细胞系的多omics数据.
- 通过使用一种新的概率数据整合方法,识别潜在的可药物治疗途径和涉及同核蛋白病变的基因.
- 优先考虑同核蛋白病变的治疗目标.
主要方法:
- 开发POPLS-DA (概率数据集成) 用于多omics分析.
- 来自LUHMES细胞系的转录组学,蛋白质组学和药物查数据的整合.
- 构建一个集成的交互网络,结合药物查数据.
主要成果:
- POPLS-DA对基因和蛋白质进行了优先排序,在同核蛋白病变中区分病例和对照.
- 工作流程突出了可使用药物的基因和途径,将HSPA5确定为关键目标.
- 功能性丰富分析揭示了突触和溶解体相关的基因集群,这些基因集群是保护性药物 (包括AT1抑制剂) 的目标.
结论:
- 计算工作流提供了一种强大的方法来分析同核蛋白病变中的多omics数据.
- HSPA5和AT1抑制剂代表了同核蛋白病变和帕金森病的有前途的治疗途径.
- 在提供更大,可解释的基因组用于目标识别方面,POPLS-DA的表现优于其他方法.
更多相关视频
相关概念视频
Combined Effects of Drugs: Synergism
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
Drug Concentrations: Measurements
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...
Plasma —...
Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...


